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Bi-antibiotic-impregnated bone cements (BIBCs) are widely used in orthopaedics as a prophylactic agent (depot) to
address post-surgical infections. Although hardness is widely considered a viable index to measure the integrity of
the cement structure, there are few specific studies involving changes in hardness characteristics of BIBCs post
elution of high doses of two widely used antibiotics: tobramycin and gentamicin. Increased doses of antibiotics and
increased duration of elution may also decrease the hardness of polymethyl methacrylate (PMMA) bone cement,
thus increasing the chances of shattering, scratching, and deformation.
In this project, we have investigated the changes in surface hardness of five different antibiotic-loaded specimens:
0.5 g tobramycin and 0.5 g gentamicin together, 1 g tobramycin, 1 g gentamicin, 5 g tobramycin and 5 g
gentamicin together, and 10 g tobramycin (each added to 40 g of PMMA), post elution for various time periods
(1, 3, and 21 days). The effect of hydration on the hardness of bone cement was studied to replicate in vivo
conditions. The micro-indentation tester (Buehler m5103) was utilized to determine if the increased antibiotic loads
would compromise the integrity of the bone cement matrix.
The results demonstrated that the amount of drug initially incorporated determined the hardness of the cement
post elution. As compared to the control (no antibiotic), specimens containing 1 and 10 g of antibiotic exhibited
over 50% and 73% decrease in hardness, respectively. The different treatment durations (post 1 day) as well as the
hydration conditions had insignificant effect on the hardness of the cement.
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Coming to prevalence around half a century ago, bone
cements are widely used in total joint replacements or
total joint arthroplasties (TJAs). Antibiotic-impregnated
bone cement (AIBC) is widely used to anchor the pros-
thetic device to the surrounding bone, thus providing
mechanical strength to the bone-implant structure
(Armstrong et al. 2002; Lewis 2009; Saha and Pal 1984;
Anagnostakos et al. 2006; Buchholz and Engelbrecht
1970; Hanssen 2004; Persson et al. 2006). Although
these procedures are highly successful, there is a possi-
bility of infection which varies from 0.5% to 3% of all
surgeries performed (Jiranek et al. 2006). If the pros-
thesis or the surrounding area becomes infected, there
are usually two options, one being exchange arthro-
plasty, where the original prosthesis is removed through* Correspondence: subrata.saha@downstate.edu
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in any medium, provided the original work is pdebridement and replaced. The more prevalent and
more successful option, however, is a two-stage revision
arthroplasty. In a two-stage revision arthroplasty, the
patient undergoes two surgeries: first, an antibiotic-
impregnated polymethyl methacrylate (PMMA) spacer is
implanted at the site of infection that serves to hold the
joint in place, providing a direct and quick therapeutic
effect and acting as a temporary prosthesis. In the
second, an aseptic prosthesis replaces the spacer. In
many cases, the AIBC is used as a means of prophylaxis
(Cui et al. 2007; Masri et al. 1998). The antibiotic leaches
out from the cement matrix and provides protection
against pathogens (He et al. 2002; Hendriks et al. 2004;
Hofmann et al. 2005; Hsieh et al. 2005; Joseph et al. 2003).
Recently, there have been instances of antibiotic-
resistant pathogens, and to counter such organisms,
clinicians are increasingly using two different broad-
spectrum antibiotics (tobramycin and gentamicin) at
high doses (Durbhakula et al. 2004; Greene et al. 1998;n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Unfortunately, at higher doses, antibiotics may deterior-
ate the mechanical properties of PMMA (Ong et al.
2009; Baleani et al. 2003; Lewis 2008; Simpson et al.
2005; Baleani et al. 2008). Studies indicate that the elution
of antibiotics involves a quick burst release from the
cement surface that is exposed to blood/body fluids within
the first few hours followed by a slow release of antibiotics
over several weeks. During longer elution durations, more
pores/channels are created within the matrix, thus facilitat-
ing further release of antibiotics but nonetheless comprom-
ising the cement structure (Anagnostakos and Kelm 2009).
Hence, studying and understanding the biomechanical
properties as a result of increased antibiotic doses and
elution times have become more important and relevant.
Although the hardness of bi-antibiotic-impregnated
bone cement (BIBC) pre- and post elution is of much
significance, there are few specific studies on this im-
portant biomechanical characteristic. As more pores are
created either through increased elution times or anti-
biotics, the PMMA cement becomes more susceptible to
deformation, shattering, and scratching, destroying the
prosthesis and submitting the patient to more surgeries,
difficulties, and inconvenience. This study on hardness vs.
elution times and increased antibiotic dosages demon-
strates the increased susceptibility to these problems.
The purpose of this study was twofold: tests were done
to discern any significant change in hardness of Simplex
PW bone cement after increased elution times of genta-
micin and tobramycin (1, 3, and 21 days) and after
increased doses. Previous investigators have extensively
studied the elution of antibiotics from bone cement and
corresponding changes in biomechanical properties, but
hardness tests are not well investigated. Past researchers
have primarily tested the effects of vacuum mixing
versus hand-mixing (Zivic et al. 2012). Hand-mixing
increases the amount of pores present in PMMA; conse-
quently, deformation/hardness tests provided evidence
that hardness increased as the PMMA cement was
vacuumed for longer periods of time. To the best of our
knowledge, this is the first study involving the investiga-
tion of change in hardness of BIBC following elution of
varying doses (1 to 10 g) of tobramycin and gentamicin
at varying time periods (1 day to 3 weeks).
Results
Tests were conducted to study changes in hardness of
AIBC following increased elution times and antibiotic
loads. The hypothesis was that with increased elution
times and antibiotic loads, hardness would decrease and
show a negative correlation and linear relationship. To
simulate actual in situ conditions, wet samples were
also examined. No significant differences were observedbetween the hardness values of wet vs. dry samples
(p < 0.05). The hypothesis was proved correct for increased
antibiotic loads. For all elution times, a strong negative re-
lationship was observed, with no Pearson correlation co-
efficient falling below −0.7 (in absolute value). Also, all
p values were <0.05, further signifying a significant
correlation.
As shown in Figure 1, there was a significant decrease
(p < 0.05) in hardness between the control and all AIBC
specimens at all time points. All data are mean ± standard
deviation (SD). The ‘asterisk’ indicates p ≤ 0.05 (significant
difference between control and individual treatments
for all groups), and the ‘number sign’ indicates p ≤ 0.05
(significant difference in hardness values was observed
between the low dose (1 g) and high dose (10 g) of anti-
biotics when compared to each other and to the
control). Interestingly, there was no time-dependent sig-
nificant decrease in hardness values beyond 24 h for any
group. Also, at any particular time period, the groups
exhibited dose-dependent hardness values. For group A,
at 1 day, there was a 50% decrease in hardness as com-
pared to the control, which is significantly different
from specimens treated for 21 days. Likewise, the other
groups exhibited a similar surface hardness profile at all
time periods. However, when we consider groups D and
E that have a higher antibiotic/PMMA ratio, they exhib-
ited a greater decrease in hardness values. For example,
specimens of group D at 1 day exhibited over 73% de-
crease in hardness as compared to the control, which
increased to 78% at 21 days. Group E also exhibited a
significant decrease in the hardness value (70%), which
does not change significantly with time. A plausible ex-
planation may be that the hardness testing was per-
formed on the surface, and most of the drug present on
the surface had already eluted by 24 h. This, however,
does not change with increasing elution time. It is only
dependent on the initial amount of drug that was incor-
porated. Few disparities that were observed in this
otherwise general trend may be attributed to varying
surface properties of the AIBC, even among specimens
of the same group.
Table 1 shows the change in hardness values (MPa) at
various elution time periods and increasing antibiotic
doses. The control had a hardness of 321.9 ± 61.1 MPa,
which was significantly greater than the hardness of all
specimen groups. Moreover, for the groups that had the
same antibiotic/PMMA ratio, we did not observe a sig-
nificant difference in hardness values for all the time
periods. There was a significant decrease in hardness
values when the amount of drug was increased from 1
to 10 g for every 40 g of PMMA. Even within the same
time periods, the specimen groups containing 1 g of
antibiotic exhibited over a 50% decrease in hardness as
compared to the control followed by a further 23%
Figure 1 Graph showing hardness values (Y axis) and the various groups/time periods (X axis). All data are mean ± SD.
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10 g. When two different antibiotics were mixed in place
of a single antibiotic (same weight), there was no signifi-
cant change in hardness values. There was no relation-
ship or correlation between the hardness and increased
elution periods post 1 day.
Effect of hydration on hardness of PMMA specimen
There was no significant change in hardness characteris-
tics as a result of hydration at the various time periods
of 1, 3, and 21 days post elution. Shown in Figure 2 are
the hardness values of the various groups at 3 weeks.
Both dry and wet specimens exhibited similar hardnessTable 1 Hardness values for various groups and percentage d
Group 24 h (1 day)
MPa (%)
0.5 g G + 0.5 g T 159.0 ± 36.8 (50.6)
1 g G 159.9 ± 31.9 (50.3)
1 g T 202.7 ± 55.4 (37.0)
5 g G + 5 g T 86.7 ± 24.2 (73.1)
10 g T 95.0 ± 44.3 (70.5)
G, gentamicin; T, tobramycin.values. This may be attributed to the fact that the curing
process is accomplished within the first few hours of the
fabrication of the AIBC specimens. Beyond the first few
hours, there is very little change in volume or other phy-
sicochemical properties of the antibiotic-eluting bone
cement (AIBC) specimens.
Discussion
This study demonstrates that as the amount of antibiotic
loaded in the bone cement increases, there is a decrease
in its surface hardness post elution of antibiotics. The
decrease in hardness may be attributed to the fact that
the samples with 10 g of antibiotic content (groups Decrease compared to control at various time periods
72 h (3 days) 504 h (21 days)
MPa (%) MPa (%)
171.8 ± 47.5 (46.6) 164.8 ± 36.8 (48.8)
172.6 ± 23.5 (46.4) 140.2 ± 32.6 (56.4)
147.8 ± 28.9 (54.1) 174.9 ± 37.5 (45.7)
81.0 ± 27.4 (74.8) 69.0 ± 27.5 (78.6)
86.5 ± 27.7 (73.1) 98.3 ± 12.7 (69.5)
Figure 3 Creation and distribution of pores/channels created as
a result of inhomogeneous distribution of antibiotics.
Figure 2 Hardness values (Y axis) of dry and wet specimens post elution of bi-antibiotics. All data are mean ± SD. The star indicates
p≤ 0.05 (significant difference between low and high antibiotic dose).
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matrix. Leaching of antibiotics creates pores or cavities
within the AIBC structure, thus weakening it. Therefore,
even though increasing antibiotics might lead to a better
therapeutic effect, the structural integrity of the cement
may be compromised.
Increased elution time, after 1 day, however, does not
seem to have the same effect. Although extending the
elution process allows for more antibiotics to elute, via
the pores in the matrix and along the surface, it is not
enough to demonstrate that the cement is more prone
to shattering, scratching, or deformation. However, 3
weeks is the maximum elution period tested in this pro-
ject, and it does not mean that higher elution times will
not decrease hardness, but with regard to the data
exhibited in the study, the length of time the load-
bearing PMMA bone cement is allowed to stay within
the patient before the second surgery of two-stage revi-
sion arthroplasty is not detrimental to its structural in-
tegrity. This exemplifies an important point. A decrease
in hardness, which signifies an increased chance of de-
formation and shattering of the prosthesis, is caused by
increased antibiotic loads. However, increasing elution
times, as per these data, does not compromise the struc-
tural integrity significantly.
Tests were conducted only on the surface of the
cement, indicating that during the burst elution phase,
the surface hardness of AIBC deteriorates, thus weaken-
ing the structural integrity of the cement. Future studies
should test for the change in hardness not only along
the surface, but also in the interior of the bone cement
matrix. This might help to further enforce the theorybehind the burst phase phenomenon. Care should be
taken in mixing the antibiotics and the PMMA as homo-
genously as possible, lack of which may result in uneven
distribution of the antibiotics on the surface as well as
within the core of the matrix. In such cases, the physical
properties of the specimen may vary even within the
same group. Figure 3 shows the presence of pores/chan-
nels on the surface of the scaffold and their distribution.
Future studies will involve smaller increases in the
antibiotic loads. Further investigations need to be pur-
sued to understand the change in hardness prior to 24 h.
This may be accomplished by having few time points
within the 24-h period itself. This will also provide infor-
mation about the initial burst release phenomenon.
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simulate in situ conditions; however, there have been
other experiments where bone tissue hardness was
tested in living humans. A study by Diez-Perez et al.
(2010) analyzed bone tissue in vivo; in addition, their ex-
perimentation was to discern if there is a bone hardness
difference between osteoporotic patients and patients
without this ailment. Similar to our own investigation,
they used a micro-indentation machine and used a refer-
ence point indentation, and with the use of a local
anesthetic, a patient was tested for bone hardness. Un-
like the machine used in our experiment, indentations
were measured by a specific amount of force applied
to the bone and the length of the indentation made
was recorded. Although their results indicated that
patients with osteoporosis were in fact weaker than
patients without the disease, they did not find any
correlation between the bone hardness and the age of
the patient.
More recently, Zivic et al. (2012) studied deformation
characteristics of hand-mixed cement and vacuum-
mixed cement. Hand-mixing increased the amount of
pores, compromising the structural integrity of the bone
cement and being more prone to deformation (i.e.,
decreased hardness). After vacuuming, there was a de-
crease in the amount of pores; consequently, hardness
increased.
A more holistic understanding of PMMA bone cement
and its mechanical properties can be found by incorpor-
ating not just compression and fatigue studies, but also
hardness studies on the same samples. Moreover, com-
paring these properties against the two types of prepar-
ation, vacuum vs. hand-mixing, leads to a comprehensive
acumen that will allow for the most optimally fabricated
AIBC for patients who undergo TJAs.
Appropriate hardness is one of the important criteria
that determine the long-term success of AIBC scaffolds
post arthroplasty. The release of antibiotics from such
matrices and the corresponding change in biomechanical
characteristics (including hardness) are indicators of the
longevity of AIBC. The purpose of bone cement in the
first place is to anchor the bone as well as to distribute
the load and prevent stress shielding. Antibiotics are
added as a therapeutic agent to counter potential infec-
tions post surgery. The hardness of the bone depends on
its location in the body as well as its load-bearing prop-
erties, and the biomechanical properties of the bone
cement should be similar to those of the adjacent bone.
Hengsberger et al. (2001) calculated the hardness to be
from 0.6 ± 0.11 GPa for compact bone to 1.1 ± 0.17 GPa
for trabecular bone. Zysset et al. (1999) found it to be
between 0.234 GPa for trabecular bone and 0.76 GPa for
compact bone. These values are in close agreement to
our own results. The control specimen (no antibiotics) hada hardness of 321.9 ± 61.1 MPa, while the other extreme of
10 g of antibiotic had a hardness of 72.2 ± 7.7 MPa.
Most bone cement samples exhibited a burst release
during the first 3 h followed by sustained release over
the rest of the duration of release. About 4.3% of genta-
micin present in the matrix was released from the sam-
ples containing gentamicin alone as compared to 18.6%
for samples containing tobramycin alone.
Following the burst release of antibiotics during initial
few hours of elution, all the antibiotics present at the
surface of the scaffold elute, resulting in the creation of
pores/channels as revealed by scanning electron micros-
copy. This results in the decrease of surface hardness.
The greater the initial dose and volume fraction of the
antibiotics, the greater is the decrease in the hardness.
Further investigations need to optimize the antibiotic
dose that will not significantly decrease the surface hard-
ness below a clinically acceptable limit.
There are few points to consider when studying bio-
mechanical characterization of AIBCs: (a) homogeneity
of distribution of the antibiotics, particularly on the sur-
face; (b) volume ratio of the antibiotics to PMMA; and
(c) varying surface porosities of the AIBC. To the know-
ledge of the authors, there have been no specific studies
on the hardness of PMMA bone cement with regard to
loaded bi-antibiotics and long elution times. Further
studies on hardness should be initiated as they provide
another means of testing the strength of the bone.
Conclusions
Hardness of AIBC is an important biomechanical
parameter that helps determine the long-term success of
implant devices. As a higher antibiotic dose compro-
mises the hardness as well as other mechanical proper-
ties, the dose of such additives should be optimized. The
results demonstrate that (a) there was no significant dif-
ference in the hardness values between wet and dry
specimens and (b) there was minimal correlation be-
tween the duration of elution and the hardness of the
specimens, although there was a significant decrease in
hardness as the antibiotic concentration was increased
(p ≤ 0.05). Further experimentation would have to be
done to investigate the hardness against elution kinetics
between hand-mixed specimen and vacuum-mixed
specimen. This study has added necessary information
illustrating that hardness is compromised as antibiotic
concentrations increase; this allows future prosthesis
operations to adjust their antibiotic concentrations to
attain the best antibiotic therapy without compromising
the hardness significantly.
Methods
All tests were conducted on Simplex PW (Stryker/How-
medica Osteonics, Limerick, Ireland) bone cement with/
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and gentamicin (as salts), were acquired from Sigma
(cat. #T1783-500MG for tobramycin and cat. #G3632-
10G for gentamicin; St. Louis, MO, USA). Various groups
of AIBC were fabricated: group A (0.5 g each of tobra-
mycin + gentamicin/40 g PMMA), group B (1 g gentami-
cin/40 g PMMA), group C (1 g tobramycin/40 g PMMA),
group D (5 g each of tobramycin + gentamicin/40 g
PMMA), and group E (10 g tobramycin/40 g PMMA).
When the batches were created, the already mixed
PMMA antibiotic was added to a liquid monomer,
methyl methacrylate, in a stainless steel bowl and mixed
with a stainless steel spatula at room temperature in a
fume hood. It was then poured into custom-made poly-
tetrafluoroethylene (PTFE) molds having cylindrical
pores with dimensions of 6.0 mm × 12.0 mm (diameter ×
height). Thereafter, the molds were fastened between
two solid PTFE plates for 1 h. After solidification, the
cylindrical molds were grated against a 240-grit silicon
carbide grinding disc that removed excess material and
paralleled the two surfaces of the molds. Twelve speci-
mens were taken from each set of antibiotic loads, add-
ing up to a total of 60 specimens across all antibiotic
combinations.
The specimens were removed from the molds and
checked for defects or bubbles on the surface. The im-
perfect specimens were discarded. Internal bubbles were
also checked using a Faxitron X-ray Corporation System
(Tucson, AZ, USA). The X-rays were performed at 35
kV for 1.30 min with a mammography film. Within each
set of antibiotic loads (each group), four specimens were
identified for each time period. Finally, before testing,
the four specimens (for each group and each time
period) were separated into two groups (two specimens
in each group): one group was tested dry and the other
wet, to study the effect of hydration.
The antibiotic in each specimen was allowed to elute
in buffered saline (PBS) in a shaker for the predeter-
mined time periods of 1, 3, and 21 days. At each time
period, the specimens were retrieved and kept aside in
clean, capped tubes at room temperature. For wet sam-
ples, each specimen was soaked in double-distilled (dd)
H2O for 1 h prior to testing.
Protocol for hardness testing
The Buehler m5103 micro-indentation machine (Lake
Bluff, IL, USA) was used. The instrument was balanced
and the swizzle pad was removed from the stage to create
a more stable surface for indentation. The micro-indenter
system was tested on an aluminum bar, and the units of
measurement were set to be hard Vickers pyramid num-
ber (HV) meant for metals in the Vickers scale. The pure
aluminum bar has a value of 167 HV, and values recorded
had a mean of 164.2 HV. The indents were made on theflat surface of the cylindrical samples because the results
were more consistent when tested against the hardness
for pure aluminum.
Before tests on the bone cement were initiated, the scale
was set to soft HV meant for nonmetals in the Vickers
scale, and the weight was set to 500 g. The ocular was
checked and calibrated. The stable block given in the Bueh-
ler m5103 micro-indenter was placed on the indentation
stage, and the bone cement cylinders were placed on top of
the stable block vertically. Each sample was indented for an
average of seven to eight times to account for the porosity
and nonuniformity of PMMA. Objective lens A (MIO
0.25/∞) was used to observe and measure the indents.
The indentation machine would record the values in the
Vickers scale, in units of HV, which were later converted
into megaPascals using a conversion constant, 9.807. For
wet testing, the specimens were placed in dd H2O for 1 h
prior to following the method followed for dry samples.
Statistical analysis
Statistics was done on these groups to test for correl-
ation or a linear relationship between hardness and
increased antibiotic loads and then between hardness
and increased elution times. A Pearson correlation coef-
ficient was calculated for hardness values and antibiotic
loads. A Pearson coefficient of −1 (r = −1) indicates a
perfect negative relationship: as one variable increases,
the other decreases. A Pearson coefficient of 1 (r = 1)
indicates a perfect positive relationship: as one variable
increases, the other increases. The coefficients do not,
on the other hand, indicate the strength of the relation-
ship. P values were also calculated for correlation at a
significance level of α = 0.05, with a null hypothesis of r
= 0 and a research hypothesis of r ≠ 0. P values less than
0.05 indicated a correlation, whether positive or nega-
tive, while p values greater than 0.05 indicate no
correlation.
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